Joslin Diabetes Center
103
13
21
73
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
4.9%
5 terminated/withdrawn out of 103 trials
93.6%
+7.1% vs industry average
10%
10 trials in Phase 3/4
37%
27 of 73 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (103)
Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans
Role: collaborator
Kidney Precision Medicine Project (KPMP) - COVID-19 Protocol
Role: collaborator
Evaluating the Effect of Diabetes Control Through Intensive Lifestyle Modifications on Diabetic Peripheral Neuropathy
Role: lead
Evaluation of Intra-Abdominal Fat in Patients With Type 2 Diabetes Using a Non-Invasive Method
Role: lead
The REST Study for CGM Use in Older Adults With Insulin-treated Diabetes
Role: lead
Kidney Precision Medicine Project
Role: collaborator
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
Role: collaborator
Diabetes Body Project 2
Role: lead
Postnatal Exercise to Activate Baby's Brown Fat
Role: lead
Healthy And Positive Pathways for Young People With Type 1 Diabetes (HAPPY T1D)
Role: lead
Glucagon Dose-Response in Patients With Post-Bariatric Hypoglycemia
Role: lead
Mechanisms of Hypoglycemia in Patients Without Diabetes
Role: lead
Hypoglycemia and the Gut Microbiome
Role: lead
Impact of Metabolic Health on Sperm Epigenetic Marks in Humans
Role: lead
Nutrition+: Effect of a High-Protein Diabetes Formula on Body Composition in Type 2 Diabetes Patients Treated With Incretin Mimetics
Role: lead
External Carotid Blood Flow in Individuals With Post-Bariatric Hypoglycemia
Role: lead
The Physiology of Human Brown Adipose Tissue
Role: collaborator
Continuous Glucose Monitoring (CGM) in Long Term Care (LTC) Facilities
Role: lead
Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes
Role: lead
Evaluating the Health Outcomes of the Joslin Why WAIT? Program
Role: lead